BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

755 related articles for article (PubMed ID: 31281536)

  • 1. Liquid biopsy in ovarian cancer: recent advances in circulating extracellular vesicle detection for early diagnosis and monitoring progression.
    Chang L; Ni J; Zhu Y; Pang B; Graham P; Zhang H; Li Y
    Theranostics; 2019; 9(14):4130-4140. PubMed ID: 31281536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular vesicle-based liquid biopsy holds great promise for the management of ovarian cancer.
    Zheng X; Li X; Wang X
    Biochim Biophys Acta Rev Cancer; 2020 Aug; 1874(1):188395. PubMed ID: 32698041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular vesicles: the next generation of biomarkers for liquid biopsy-based prostate cancer diagnosis.
    Pang B; Zhu Y; Ni J; Thompson J; Malouf D; Bucci J; Graham P; Li Y
    Theranostics; 2020; 10(5):2309-2326. PubMed ID: 32089744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular vesicles for liquid biopsy in prostate cancer: where are we and where are we headed?
    Minciacchi VR; Zijlstra A; Rubin MA; Di Vizio D
    Prostate Cancer Prostatic Dis; 2017 Sep; 20(3):251-258. PubMed ID: 28374743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular Vesicles: A Brief Overview and Its Role in Precision Medicine.
    Shang M; Ji JS; Song C; Gao BJ; Jin JG; Kuo WP; Kang H
    Methods Mol Biol; 2017; 1660():1-14. PubMed ID: 28828643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular vesicles and encapusulated miRNAs as emerging cancer biomarkers for novel liquid biopsy.
    Yoshioka Y; Katsuda T; Ochiya T
    Jpn J Clin Oncol; 2018 Oct; 48(10):869-876. PubMed ID: 30169666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular vesicles as source for the identification of minimally invasive molecular signatures in glioblastoma.
    Rackles E; Lopez PH; Falcon-Perez JM
    Semin Cancer Biol; 2022 Dec; 87():148-159. PubMed ID: 36375777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The emerging clinical potential of circulating extracellular vesicles for non-invasive glioma diagnosis and disease monitoring.
    Hallal S; Ebrahimkhani S; Shivalingam B; Graeber MB; Kaufman KL; Buckland ME
    Brain Tumor Pathol; 2019 Apr; 36(2):29-39. PubMed ID: 30859343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular Vesicles: Recent Developments in Technology and Perspectives for Cancer Liquid Biopsy.
    Nazarenko I
    Recent Results Cancer Res; 2020; 215():319-344. PubMed ID: 31605237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of benign peritoneal fluid- and ovarian cancer ascites-derived extracellular vesicle RNA biomarkers.
    Yamamoto CM; Oakes ML; Murakami T; Muto MG; Berkowitz RS; Ng SW
    J Ovarian Res; 2018 Mar; 11(1):20. PubMed ID: 29499737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular vesicles as a novel source of biomarkers in liquid biopsies for monitoring cancer progression and drug resistance.
    Vasconcelos MH; Caires HR; Ābols A; Xavier CPR; Linē A
    Drug Resist Updat; 2019 Dec; 47():100647. PubMed ID: 31704541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Plasma Extracellular Vesicle Isolation and Proteomic Characterization for the Optimization of Liquid Biopsy in Multiple Myeloma.
    Reale A; Khong T; Xu R; Chen M; Mithraprabhu S; Bingham N; Spencer A; Greening DW
    Methods Mol Biol; 2021; 2261():151-191. PubMed ID: 33420989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detecting ovarian cancer using extracellular vesicles: progress and possibilities.
    Carollo E; Paris B; Samuel P; Pantazi P; Bartelli TF; Dias-Neto E; Brooks SA; Pink RC; Carter DRF
    Biochem Soc Trans; 2019 Feb; 47(1):295-304. PubMed ID: 30700499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging methods in biomarker identification for extracellular vesicle-based liquid biopsy.
    Liang Y; Lehrich BM; Zheng S; Lu M
    J Extracell Vesicles; 2021 May; 10(7):e12090. PubMed ID: 34012517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging Nanotechnologies for Liquid Biopsy: The Detection of Circulating Tumor Cells and Extracellular Vesicles.
    Li W; Wang H; Zhao Z; Gao H; Liu C; Zhu L; Wang C; Yang Y
    Adv Mater; 2019 Nov; 31(45):e1805344. PubMed ID: 30589111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-coding RNAs as biomarkers in liquid biopsies with a special emphasis on extracellular vesicles in urological malignancies.
    Zeuschner P; Linxweiler J; Junker K
    Expert Rev Mol Diagn; 2020 Feb; 20(2):151-167. PubMed ID: 31499007
    [No Abstract]   [Full Text] [Related]  

  • 17. Genomic Landscape of Liquid Biopsy for Hepatocellular Carcinoma Personalized Medicine.
    Moldogazieva NT; Zavadskiy SP; Terentiev AA
    Cancer Genomics Proteomics; 2021; 18(3 Suppl):369-383. PubMed ID: 33994362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular vesicles as mediators of cell-cell communication in ovarian cancer and beyond - A lipids focus.
    Rani S; Lai A; Nair S; Sharma S; Handberg A; Carrion F; Möller A; Salomon C
    Cytokine Growth Factor Rev; 2023 Oct; 73():52-68. PubMed ID: 37423866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein biomarkers in breast cancer-derived extracellular vesicles for use in liquid biopsies.
    Li D; Lai W; Fan D; Fang Q
    Am J Physiol Cell Physiol; 2021 Nov; 321(5):C779-C797. PubMed ID: 34495763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liquid biopsy in ovarian cancer: the potential of circulating miRNAs and exosomes.
    Giannopoulou L; Zavridou M; Kasimir-Bauer S; Lianidou ES
    Transl Res; 2019 Mar; 205():77-91. PubMed ID: 30391474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.